𝔖 Bobbio Scriptorium
✦   LIBER   ✦

490 Carboplatin and ovarian cancer in the elderly

✍ Scribed by F. Husseini; B. Audhuy; J.C. Barats; F. Kohser

Book ID
116167244
Publisher
Elsevier Science
Year
1995
Tongue
English
Weight
138 KB
Volume
31
Category
Article
ISSN
0959-8049

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

The disposition of carboplatin in ovaria
The disposition of carboplatin in ovarian cancer patients
✍ Robert C. Gaver; Nicoletta Colombo; Michael D. Green; Alice M. George; George De πŸ“‚ Article πŸ“… 1988 πŸ› Springer 🌐 English βš– 908 KB

Carboplatin was given as a 30-min infusion to 11 ovarian cancer patients at doses of 170-500 mg/m 2. The ages, weights, and creatinine clearances (Clef) ranged from 44 to 75 years, from 44 to 74 kg, and from 32 to 101 ml/ min, respectively. Plasma, plasma ultrafiltrate (PU), and urine samples were o

FAU regulates carboplatin resistance in
FAU regulates carboplatin resistance in ovarian cancer
✍ Esther L. Moss; Mirna Mourtada-Maarabouni; Mark R. Pickard; Charles W. Redman; G πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 170 KB

## Abstract The development of chemotherapy resistance by cancer cells is complex, using different mechanisms and pathways. The gene __FAU__ (Finkel‐Biskis‐Reilly murine sarcoma virus (__F__BR‐MuSV)‐__a__ssociated __u__biquitously expressed gene) was identified through functional expression cloning